Publication Cover
Hemoglobin
international journal for hemoglobin research
Volume 44, 2020 - Issue 1
86
Views
1
CrossRef citations to date
0
Altmetric
Original Articles

Association between Different Polymorphic Markers and β-Thalassemia Intermedia in Central Iran

, , , &
Pages 27-30 | Received 16 Apr 2018, Accepted 16 Nov 2019, Published online: 03 Jan 2020

References

  • Shirzadfar H, Mokhtari N. Critical review on thalassemia: types, symptoms and treatment. Advancements Bioequiv Bioavail. 2018;1(2):15–18.
  • Hemminki K, Li X, Försti A, et al. Thalassemia and sickle cell anemia in Swedish immigrants: genetic diseases have become global. SAGE Open Med. 2015; 23;3:2050312115613097. eCollection 2015.
  • Marengo-Rowe AJ. The thalassemias and related disorders. Proc (Bayl Univ Med Cent). 2007;20(1):27–31.
  • Forget BG, Bunn HF. Classification of the disorders of hemoglobin. Cold Spring Harb Perspect Med. 2013;3(2):a011684–a011684.
  • Musallam KM, Taher AT, Rachmilewitz EA. β-Thalassemia intermedia: a clinical perspective. Cold Spring Harb Perspect Med. 2012;2(7):a013482–a013482.
  • Kelkar AJ, Moses A. Thalassemia intermedia phenotype resulting from rare combination of c.46delT [Codon15 (–T)] mutation of β globin gene and HPFH3. Clin Case Rep. 2017;5(7):1107–1110.
  • Chen W, Zhang X, Shang X, et al. The molecular basis of β-thalassemia intermedia in southern China: genotypic heterogeneity and phenotypic diversity. BMC Med Genet. 2010;11(1):31.
  • HbVar database (available at http://globin.bx.psu.edu/hbvar).
  • Kumar R, Arya V, Agarwal S. Profiling β thalassemia mutations in consanguinity and nonconsanguinity for prenatal screening and awareness programme. Adv Hematol. 2015;2015:625721.
  • Old JM, Varawalla NY, Weatherall DJ. Rapid detection and prenatal diagnosis of β-thalassaemia: studies in Indian and Cypriot populations in the UK. Lancet. 1990;336(8719):834–837.
  • Said F, Abdel-Salam A. XmnI polymorphism: relation to β-thalassemia phenotype and genotype in Egyptian children. Egypt J Med Hum Genet. 2015;16(2):123–127.
  • Bhagat S, Patra PK, Thakur AS. Fetal haemoglobin and β-globin Gene Cluster Haplotypes among Sickle Cell Patients in Chhattisgarh . J Clin Diagn Res. 2013;7(2):269–272.
  • Kumar R, Kaur A, Agarwal S. Influence of Xmn 1 Gγ (HBG2 c.-211 C→T) globin gene polymorphism on phenotype of thalassemia patients of North India. Indian J Hematol Blood Transfus. 2014;30(4):286–290.
  • Ali N, Ayyub M, Khan SA, et al. Frequency of Gγ-globin promoter –158 (C>T) XmnI polymorphism in patients with homozygous/compound heterozygous β thalassemia. Hematol Oncol Stem Cell Ther. 2015;8(1):10–15.
  • Najmabadi H, Karimi-Nejad R, Sahebjam S, et al. The β-thalassemia mutation spectrum in the Iranian population. Hemoglobin. 2001;25(3):285–296.
  • Gaaib N, Nassief AF, Al-Assi AH. Simple salting-out method for genomic DNA extraction from whole blood. Tikrit J Pure Sci. 2011;16(2):1–3.
  • Lee YJ, Park SS, Kim JY, et al. RFLP haplotypes of β-globin gene complex of β-thalassemic chromosomes in Koreans. J Korean Med Sci. 2002;17(4):475–478.
  • Motovali-Bashi M, Ghasemi T. Role of XmnIgG polymorphism in hydroxyurea treatment and fetal hemoglobin level at Isfahanian intermediate β-Thalassemia Patients. Iran Biomed J. 2015;19(3):177–182.
  • Kanavakis E, Traeger-Synodinos J, Lafioniatis S, et al. A rare example that coinheritance of a severe form of β-thalassemia and α thalassemia interact in a ‘synergistic’ manner to balance the phenotype of classic thalassemic syndromes. Blood Cells Mol Dis. 2004;32(2):319–324.
  • Arab A, Karimipoor M, Rajabi A, et al. Molecular characterization of β-thalassemia intermedia: a report from Iran. Mol Biol Rep. 2011;38(7):4321–4326.
  • Hamid M, Mahjoubi F, Akbari MT, et al. Molecular analysis of γ-globin promoters, HS-111 and 30HS1, in β-thalassemia intermedia patients associated with high levels of Hb F. Hemoglobin. 2009;33(6):428–438.
  • Neishabury M, Azarkeivan A, Najmabadi H. Frequency of positive XmnI Gγ polymorphism and coinheritance of common α thalassemia mutations do not show statistically significant difference between thalassemia major and intermedia cases with homozygous IVS-II-1 mutation. Blood Cells Mol Dis. 2010;44(2):95–99.
  • Karimi M, Yarmohammadi H, Farjadian S, et al. β-Thalassemia intermedia from southern Iran: IVS-II-1 (G→A) is the prevalent thalassemia intermedia allele. Hemoglobin. 2002;26(2):147–154.
  • Akbari MT, Izadi P, Izadyar M, et al. Molecular basis of thalassemia intermedia in Iran. Hemoglobin. 2008;32(5):462–470.
  • Azzouzi I, Moest H, Winkler J, et al. MicroRNA-96 directly inhibits γ-globin expression in human erythropoiesis. PLoS One. 2011;6(7):e22838.
  • Gabbianelli M, Testa U, Morsilli O, et al. Mechanism of human Hb switching: a possible role of the kit receptor/miR 221-222 complex. Haematologica. 2010;95(8):1253–1260.
  • Sankaran VG, Menne TF, Scepanovic D, et al. MicroRNA-15a and -16-1 act via MYB to elevate fetal hemoglobin expression in human trisomy 13. Proc Natl Acad Sci USA. 2011;108(4):1519–1524.
  • Thein SL, Menzel S, Lathrop M, et al. Control of fetal hemoglobin: new insights emerging from genomics and clinical implications. Hum Mol Genet. 2009;18(2):216–223.
  • Nguyen TKT, Joly P, Bardel C, et al. The Xmn1Gγ polymorphism influences Hemoglobin F synthesis contrary to BCL11A and HBS1L-MYB SNPs in a cohort of 57 β-thalassemia intermedia patients. Blood Cells Mol Dis. 2010;45(2):124–127.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.